Adult-Onset Genetic Central Nervous System Disorders Masquerading as Acquired Neuroinflammatory Disorders A Review

被引:10
作者
Ayrignac, Xavier [1 ,2 ,3 ,4 ]
Carra-Dalliere, Clarisse [2 ,3 ,4 ]
Marelli, Cecilia [2 ,5 ,6 ]
Taieb, Guillaume [2 ]
Labauge, Pierre [1 ,2 ,3 ,4 ]
机构
[1] Univ Montpellier, Inst Neurosci Montpellier, INSERM, Montpellier, France
[2] Montpellier Univ Hosp, Dept Neurol, 80 Rue Augustin Fliche, F-34295 Montpellier 05, France
[3] Montpellier Univ Hosp, Reference Ctr Adult Onset Leukoencephalopathy & L, Montpellier, France
[4] Montpellier Univ Hosp, Reference Ctr Multiple Sclerosis, Montpellier, France
[5] Univ Montpellier, INSERM, Ecole Prat Hautes Etud, Mol Mech Neurodegenerat Dementias, Montpellier, France
[6] Montpellier Univ Hosp, Expert Ctr Neurogenet Dis & Adult Mitochondrial &, Montpellier, France
关键词
X-LINKED ADRENOLEUKODYSTROPHY; CHRONIC LYMPHOCYTIC INFLAMMATION; HEREDITARY OPTIC NEUROPATHY; BIOTINIDASE DEFICIENCY; ALEXANDER-DISEASE; DIAGNOSTIC-CRITERIA; CLINICAL-FEATURES; TREATABLE CAUSE; BRAIN-LESIONS; SPECTRUM;
D O I
10.1001/jamaneurol.2022.2141
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IMPORTANCE Adult-onset genetic disorders may present with clinical and magnetic resonance imaging (MRI) features suggestive of acquired inflammatory diseases. An ever-growing number of potentially treatable adult-onset genetic neuroinflammatory disorders have been described in the past few years that need to be rapidly identified. OBSERVATIONS Adult-onset acquired neuroinflammatory disorders encompass a large group of central nervous system (CNS) diseases with varying presentation, MRI characteristics, and course, among which the most common is multiple sclerosis. Despite recent progress, including the discovery of specific autoantibodies, a significant number of adult-onset neuroinflammatory disorders with progressive or relapsing course still remain without a definite diagnosis. In addition, some patients with genetic disorders such as leukodystrophies, hemophagocytic lymphohistiocytosis, or genetic vasculopathies can mimic acquired neuroinflammatory disorders. These genetic disorders, initially described in pediatric populations, are increasingly detected in adulthood thanks to recent progress in molecular genetics and the larger availability of high-throughput sequencing technologies. CONCLUSIONS AND RELEVANCE Genetic adult-onset neuroinflammatory diseases are at the border between primary CNS inflammatory diseases and systemic disorders with multiorgan involvement and predominantly neurologic manifestations. Neurologists must be aware of the main clues and red flags so they can confirm a diagnosis early, when some of these genetic disorders can be successfully treated.
引用
收藏
页码:1069 / 1078
页数:10
相关论文
共 41 条
  • [31] Anti-KIR4.1 Antibodies in Chinese Patients with Central Nervous System Inflammatory Demyelinating Disorders
    Zhong, Rong
    Liang, Junyan
    Tao, Ailin
    Wu, Linzhan
    Yang, Xinguang
    Xu, Huiming
    Huang, Qingmei
    Zhuang, Shunzhi
    Long, Youming
    Gao, Cong
    NEUROIMMUNOMODULATION, 2016, 23 (5-6) : 295 - 300
  • [32] Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential
    White, Matthew L.
    Moore, Drew W.
    Zhang, Yan
    Mark, Keiper D.
    Greiner, Timothy C.
    Bierman, Philip J.
    INSIGHTS INTO IMAGING, 2019, 10 (01)
  • [33] Detection of autoantibodies in central nervous system inflammatory disorders: Clinical application of cell-based assays
    Molina, Rachel Dias
    Conzatti, Lucas Piccoli
    Bornes da Silva, Ana Paula
    Sckenal Goi, Leise Daniele
    da Costa, Bruna Klein
    Machado, Denise Cantarelli
    Sato, Douglas Kazutoshi
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 38
  • [34] Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential
    Matthew L. White
    Drew W. Moore
    Yan Zhang
    Keiper D. Mark
    Timothy C. Greiner
    Philip J. Bierman
    Insights into Imaging, 10
  • [35] Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein
    Akaishi, Tetsuya
    Sato, Douglas Kazutoshi
    Takahashi, Toshiyuki
    Nakashima, Ichiro
    NEUROCHEMISTRY INTERNATIONAL, 2019, 130
  • [36] Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study
    Vogrig, Alberto
    Tartaglia, Sara
    Dentoni, Marta
    Fabris, Martina
    Bax, Francesco
    Belluzzo, Marco
    Verriello, Lorenzo
    Bagatto, Daniele
    Gastaldi, Matteo
    Tocco, Pierluigi
    Zoccarato, Marco
    Zuliani, Luigi
    Pilotto, Andrea
    Padovani, Alessandro
    Villagran-Garcia, Macarena
    Davy, Vincent
    Gigli, Gian Luigi
    Honnorat, Jerome
    Valente, Mariarosaria
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [37] Association between myeloid disorders and adult onset-inflammatory syndromes, successful treatment with JAK-inhibitors: Case series and literature review
    Mishra, Rahul
    Calabrese, Cassandra
    Jain, Akriti G.
    Singh, Abhay
    LEUKEMIA RESEARCH, 2024, 146
  • [38] Clinical Features and Sera Anti-Aquaporin 4 Antibody Positivity in Patients with Demyelinating Disorders of the Central Nervous System from Tianjin, China
    Yang, Chun-Sheng
    Zhang, Da-Qi
    Wang, Jing-Hua
    Jin, Wei-Na
    Li, Min-Shu
    Liu, Jie
    Zhang, Cun-Jin
    Li, Ting
    Shi, Fu-Dong
    Yang, Li
    CNS NEUROSCIENCE & THERAPEUTICS, 2014, 20 (01) : 32 - 39
  • [39] Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977-2015: A nationwide population-based incidence study
    Boesen, Magnus Spangsberg
    Magyari, Melinda
    Koch-Henriksen, Nils
    Thygesen, Lau Caspar
    Born, Alfred Peter
    Uldall, Peter Vilhelm
    Blinkenberg, Morten
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (08) : 1077 - 1086
  • [40] Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders
    Matsushita, T.
    Matsuoka, T.
    Isobe, N.
    Kawano, Y.
    Minohara, M.
    Shi, N.
    Nishimura, Y.
    Ochi, H.
    Kira, J.
    TISSUE ANTIGENS, 2009, 73 (02): : 171 - 176